United Imaging Healthcare Q3 2025 Results: Overseas Revenue Up 42% YoY

United Imaging Healthcare reported overseas revenue of CNY 1.9 billion in the first three quarters of 2025, reflecting a year-over-year increase of 41.97%, now accounting for 22.5% of total company revenue23.

Total revenue for Q3 2025 was CNY 2.84 billion, up 75.41% year-on-year, and net profit attributable to ordinary shareholders after deducting non-recurring profit was CNY 0.09 billion2.

For the first three quarters of 2025, total revenue reached CNY 8.86 billion (up 27.39% YoY), and net profit attributable to ordinary shareholders after deducting non-recurring profit reached CNY 1.05 billion (up 126.94% YoY)2.

R&D investment for the first three quarters amounted to CNY 1.86 billion, a 13.5% increase year-on-year, fueling new innovations such as the uMR Ultra 3T MRI and other advanced imaging products23.

Overseas expansion was particularly strong in Asia-Pacific (Japan, South Korea, India), Latin America (notably Brazil, Mexico), and the Middle East (Turkey), aided by localized strategies and regional partnerships3.

The company's international growth strategy focused on combining regulatory agility (including FDA/CE certifications) with tailored solutions to outpace competitors in emerging markets3.

Sources:

2. https://www.barchart.com/story/news/35781832/united-imaging-healthcare-q3-2025-results-in-the-first-three-quarters-of-2025-overseas-revenue-up-42-yoy

3. https://www.ainvest.com/news/united-imaging-healthcare-global-surge-strategic-breakthrough-emerging-markets-2510/